REGULATED PRESS RELEASE published on 05/05/2025 at 09:59, 9 months 7 days ago Mersen: Number of shares and voting rights as of April 30, 2025 Mersen discloses total number of voting rights and shares in capital as of April 30, 2025, in compliance with French regulations. Mersen is a global expert in electrical power and advanced materials for high-tech industries Voting Rights Shares French Regulations Mersen Global Expert
REGULATED PRESS RELEASE published on 05/05/2025 at 09:59, 9 months 7 days ago Mersen : nombre d'actions et de droits de vote au 30 avril 2025 Déclaration des droits de vote et du capital de Mersen au 30 avril 2025. Présence mondiale dans les spécialités électriques et matériaux avancés pour les industries High-Tech Capital Déclaration Mersen Industries High-Tech Matériaux Avancés
PRESS RELEASE published on 05/05/2025 at 09:40, 9 months 7 days ago Ministry of Foreign and European Affairs Showcases Decent Cybersecurity at Innovation Day on Cybersecurity Ministry of Foreign and European Affairs showcases Decent Cybersecurity's post-quantum solutions at Innovation Day on Cybersecurity, highlighting Slovakia's leadership in advanced technologies and public-private partnerships Cybersecurity Innovation Day Slovakia Decent Cybersecurity Post-quantum Solutions
PRESS RELEASE published on 05/05/2025 at 09:15, 9 months 7 days ago Accelleron focuses on growth in injection systems and invests in Italy Accelleron's subsidiary OMT invests in Italy to expand production capacities and strengthen technological leadership in fuel injection systems, aiming to double revenue to USD 150 million by 2029. Total investments of USD 80 million planned Italy Investment Accelleron Fuel Injection OMT
PRESS RELEASE published on 05/05/2025 at 09:13, 9 months 7 days ago Roquette Announces a New Organizafion following the Acquisifion of IFF Pharma Solufions Roquefte successfully completes the acquisition of IFF Pharma Solutions, strengthening its position in the pharmaceutical industry and reinforcing commitment to innovation Acquisition Innovation Pharmaceutical Industry IFF Pharma Solutions Roquefte
PRESS RELEASE published on 05/05/2025 at 09:05, 9 months 7 days ago BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization BioNxt Solutions Inc. announces acceptance of its first national level patent filing by Eurasian Patent Organization, covering sublingual drug delivery for neurodegenerative diseases BioNxt Solutions Inc. Patent Filing Neurodegenerative Diseases Sublingual Delivery Eurasian Patent Organization
PRESS RELEASE published on 05/05/2025 at 08:35, 9 months 7 days ago Eurobattery Minerals passed the first phase of evaluation in European Funding Call Eurobattery Minerals AB's funding application to the 'ERMA Booster Call 2025' program passes first evaluation phase, advancing to next stage. Company emphasizes project's importance for Europe's raw materials resilience and competitiveness Europe Eurobattery Minerals AB Raw Materials ERMA Booster Call 2025 Funding Application
REGULATED PRESS RELEASE published on 05/05/2025 at 08:30, 9 months 7 days ago NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA permettant de mieux décrire l’effet de NFL-101, son traitement first in class contre l’addiction au tabac, mettant notamment en évidence son activité prolongée NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA sur l'effet prolongé de NFL-101 contre l'addiction au tabac. Nouvelles données sur les zones cérébrales ciblées par le traitement NFL Biosciences NFL-101 CEA Étude Addiction Au Tabac
REGULATED PRESS RELEASE published on 05/05/2025 at 08:30, 9 months 7 days ago NFL Biosciences announces results from a new study conducted with the CEA providing further insight into the effects of NFL-101, its first-in-class treatment for tobacco addiction, and highlighting its prolonged activity NFL Biosciences announces results from a new study with CEA on NFL-101, a treatment for tobacco addiction, highlighting prolonged activity & unique effect, showcased via PET imaging NFL Biosciences CEA Study NFL-101 Tobacco Addiction Prolonged Activity
PRESS RELEASE published on 05/05/2025 at 08:30, 9 months 7 days ago Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
Published on 02/13/2026 at 00:20, 2 hours 48 minutes ago Southern Energy Corp. Completes US$23.5 Million Financings and Royalty Sale
Published on 02/13/2026 at 00:10, 2 hours 58 minutes ago Irving Resources Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 02/12/2026 at 23:25, 3 hours 43 minutes ago The Caldwell Partners International Announces Results of Vote for Election of Directors
Published on 02/12/2026 at 22:00, 5 hours 8 minutes ago Electrovaya Reports Fiscal Year Q1 2026 Results
Published on 02/12/2026 at 19:18, 7 hours 50 minutes ago Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
Published on 02/12/2026 at 21:16, 5 hours 52 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 02/12/2026 at 21:15, 5 hours 53 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 02/12/2026 at 21:14, 5 hours 53 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 02/12/2026 at 21:13, 5 hours 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 02/12/2026 at 21:13, 5 hours 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc
Published on 02/12/2026 at 21:30, 5 hours 37 minutes ago Aéroports de Paris SA - 2026 Airport charges in Paris
Published on 02/12/2026 at 21:30, 5 hours 37 minutes ago Aéroports de Paris SA - Processus d'homologation tarifaire 2026
Published on 02/12/2026 at 17:45, 9 hours 23 minutes ago MR.BRICOLAGE SA: ENTERING INTO A NEW SYNDICATED CREDIT FACILITY